mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
1e-07 |
mRNA |
AZD-2281 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
3e-07 |
mRNA |
decitabine |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
7e-07 |
mRNA |
alisertib |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
1e-06 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
4e-06 |
mRNA |
CCT036477 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
4e-06 |
mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
5e-06 |
mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
8e-06 |
mRNA |
ciclopirox |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
1e-05 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
2e-05 |